Xilin Du

1.9k total citations
58 papers, 1.5k citations indexed

About

Xilin Du is a scholar working on Molecular Biology, Hepatology and Surgery. According to data from OpenAlex, Xilin Du has authored 58 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 19 papers in Hepatology and 15 papers in Surgery. Recurrent topics in Xilin Du's work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Liver Disease Diagnosis and Treatment (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). Xilin Du is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Liver Disease Diagnosis and Treatment (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). Xilin Du collaborates with scholars based in China and United States. Xilin Du's co-authors include Wei‐Cheng Yuan, Zhijun Wu, Xiaomei Zhang, Wenbing Chen, Yu‐Hua Liao, Linfeng Cun, Jianguo Lu, Xiong‐Li Liu, Tao Wu and Jianguo Lu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Bioresource Technology.

In The Last Decade

Xilin Du

56 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xilin Du China 23 557 511 240 183 169 58 1.5k
Shiho Arima Japan 22 447 0.8× 443 0.9× 66 0.3× 54 0.3× 190 1.1× 122 1.3k
Natale D’Alessandro Italy 23 265 0.5× 887 1.7× 234 1.0× 68 0.4× 63 0.4× 57 1.6k
Pierre Bischoff France 19 220 0.4× 455 0.9× 122 0.5× 31 0.2× 92 0.5× 39 1.0k
Haoliang Yuan China 21 282 0.5× 697 1.4× 58 0.2× 57 0.3× 46 0.3× 71 1.2k
Yong‐ju Liang China 27 306 0.5× 1.1k 2.2× 171 0.7× 46 0.3× 196 1.2× 43 2.2k
Antonella Miglietta Italy 22 93 0.2× 699 1.4× 277 1.2× 202 1.1× 111 0.7× 40 1.4k
David N. Deaton United States 23 303 0.5× 549 1.1× 147 0.6× 38 0.2× 133 0.8× 48 1.2k
Chengguang Zhao China 25 258 0.5× 1.0k 2.0× 281 1.2× 15 0.1× 67 0.4× 47 1.9k
Yahui Ding China 23 280 0.5× 976 1.9× 506 2.1× 44 0.2× 58 0.3× 87 1.8k
Chao‐Yun Cai China 24 216 0.4× 862 1.7× 179 0.7× 26 0.1× 117 0.7× 40 1.6k

Countries citing papers authored by Xilin Du

Since Specialization
Citations

This map shows the geographic impact of Xilin Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xilin Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xilin Du more than expected).

Fields of papers citing papers by Xilin Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xilin Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xilin Du. The network helps show where Xilin Du may publish in the future.

Co-authorship network of co-authors of Xilin Du

This figure shows the co-authorship network connecting the top 25 collaborators of Xilin Du. A scholar is included among the top collaborators of Xilin Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xilin Du. Xilin Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Kai Chah, et al.. (2023). The feasibility and safety of the brachial artery approach in the treatment of hepatic artery infusion chemotherapy: a retrospective study. Journal of Gastrointestinal Oncology. 14(4). 1830–1836. 1 indexed citations
2.
Yang, Zhenyu, Yao Tong, Lin Yang, et al.. (2021). Identifying optimal therapies in patients with advanced hepatocellular carcinoma: a systematic review and network meta-analysis. Translational Gastroenterology and Hepatology. 7. 38–38. 4 indexed citations
3.
Zhao, Shoujie, et al.. (2020). Comparison between Child-Pugh score and Albumin-Bilirubin grade in the prognosis of patients with HCC after liver resection using time-dependent ROC. Annals of Translational Medicine. 8(8). 539–539. 38 indexed citations
4.
Yang, Jiandong, Chong Chen, Jiachen Sun, et al.. (2016). FLIPL is critical for aerobic glycolysis in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 35(1). 79–79. 18 indexed citations
5.
Zhang, Hongke, et al.. (2016). Magnetic compression anastomosis for enteroenterostomy under peritonitis conditions in dogs. Journal of Surgical Research. 208. 60–67. 14 indexed citations
6.
Lu, Jianguo, Rui Dong, Tao Yang, et al.. (2015). Targeted sequencing of cancer-associated genes in hepatocellular carcinoma using next generation sequencing. Molecular Medicine Reports. 12(3). 4678–4682. 12 indexed citations
7.
Dong, Rui, Xilin Du, Qing Wang, et al.. (2014). Laparoscopic versus open splenectomy plus pericardial devascularization for portal hypertension. Zhonghua putong waike zazhi. 29(2). 105–107. 1 indexed citations
8.
9.
Feng, Xiaobin, Ruocai Xu, Xilin Du, et al.. (2014). Combination Therapy With Sorafenib and Radiofrequency Ablation for BCLC Stage 0–B1 Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study. The American Journal of Gastroenterology. 109(12). 1891–1899. 59 indexed citations
10.
Li, Tao, Lijuan Yuan, Shouli Wang, et al.. (2014). Downregulation of microRNA-139 is associated with hepatocellular carcinoma risk and short-term survival. Oncology Reports. 31(4). 1699–1706. 49 indexed citations
11.
Yin, Jikai, Lijuan Yuan, Ziyu Liu, et al.. (2014). Recombinant fusion proteins FPTD-Grb2-SH2 and FPTD-Grb2-SH2M inhibit the proliferation of breast cancer cells in vitro. Oncology Reports. 31(6). 2669–2675. 1 indexed citations
12.
Zhang, Li, Jiän Zhang, Xianli He, et al.. (2013). A recombined fusion protein PTD-Grb2-SH2 inhibits the proliferation of breast cancer cells in vitro. International Journal of Oncology. 42(3). 1061–1069. 10 indexed citations
13.
Bao, Guoqiang, Tao Wu, Chengguo Wang, et al.. (2012). Strong Inhibition of UDP-Glucuronosyltransferase (UGT) 1A1 by Levothyroxine Indicates the Potential UGT-Inhibition Based Adverse Effect of Levothyroxine. Latin American Journal of Pharmacy. 2 indexed citations
14.
Li, Jinmao, Tao Wu, Jianguo Lu, et al.. (2012). Immunohistochemical evidence of the prognostic value of hedgehog pathway components in primary gallbladder carcinoma. Surgery Today. 42(8). 770–775. 22 indexed citations
15.
Du, Xilin, Huadong Zhao, Li Zang, et al.. (2012). Overexpression of Histone Deacetylase 2 Predicts Unfavorable Prognosis in Human Gallbladder Carcinoma. Pathology & Oncology Research. 19(3). 397–403. 6 indexed citations
16.
Wang, Nan, Xilin Du, Li Zang, et al.. (2012). Prognostic impact of Metadherin–SND1 interaction in colon cancer. Molecular Biology Reports. 39(12). 10497–10504. 43 indexed citations
17.
18.
Wang, Chengguo, Huadong Zhao, Jianguo Lu, et al.. (2012). Clinicopathological significance of SOX4 expression in primary gallbladder carcinoma. Diagnostic Pathology. 7(1). 41–41. 32 indexed citations
19.
Li, Yaqian, Xilin Du, Zhi John Lu, et al.. (2011). Regulatory Feedback Loop of Two phz Gene Clusters through 5′-Untranslated Regions in Pseudomonas sp. M18. PLoS ONE. 6(4). e19413–e19413. 28 indexed citations
20.
Li, Yaqian, Haixia Jiang, Xilin Du, et al.. (2010). Enhancement of phenazine-1-carboxylic acid production using batch and fed-batch culture of gacA inactivated Pseudomonas sp. M18G. Bioresource Technology. 101(10). 3649–3656. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shiho Arima Breakdown of academic impact, for papers by Natale D’Alessandro Breakdown of academic impact, for papers by Pierre Bischoff Breakdown of academic impact, for papers by Haoliang Yuan Breakdown of academic impact, for papers by Yong‐ju Liang Breakdown of academic impact, for papers by Antonella Miglietta Breakdown of academic impact, for papers by David N. Deaton Breakdown of academic impact, for papers by Chengguang Zhao Breakdown of academic impact, for papers by Yahui Ding Breakdown of academic impact, for papers by Chao‐Yun Cai
Rankless by CCL
2026